2002

Oct 11, 2002
Guidant Receives FDA Approval for its Next Generation Heart Failure Technology

Small, Physiologic-shaped CONTAK CD 2 System Combines Treatment for Both Heart Failure and Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a...

Oct 9, 2002
Guidant Announces Live Webcast of its Third Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its third quarter 2002 earnings...

Oct 3, 2002
Guidant Receives Humanitarian Device Exemption for New Intracranial Stent

NEUROLINK Stent May Provide Hope for Patients at High Risk for Recurrent Stroke Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Oct 2, 2002
Guidant Comments on Cook-Boston Scientific Litigation

Conference Call/Webcast Scheduled at 11AM EDT Today Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) reported that the United States District Court for the Northern District of...

Oct 1, 2002
Guidant Announces European Market Launch of Next-Generation Implantable Defibrillators

World''s smallest, thinnest defibrillator offers advanced rhythm discrimination and industry-leading longevity Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a...

Oct 1, 2002
Guidant Announces FDA Clearance and Worldwide Launch of New Product for Treating Peripheral Vascular Disease

High-Performance, Low-Profile System Offers Physicians New Option Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac...

Sep 30, 2002
Guidant Announces Preliminary Results of Largest Drug Eluting Stent Trial To Date

Early Data from 1,533-Patient Trial Supports Safety of Paclitaxel Eluting Stents In High-Risk Patients Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Sep 27, 2002
Guidant Announces Results of Key Study In Emerging Field of Heart Attack Prevention

Vulnerable Plaque Presents Significant Opportunity for Preventive Therapy Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Sep 25, 2002
Guidant Commends New Guideline for Defibrillator Implants

New Guideline Reflects Results of MADIT II Trial Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...

Sep 24, 2002
Guidant Launches Next-Generation Radiotherapy System in the United States

System Designed to Enable Physicians to Treat Long Vessel Blockages With Ease and Precision Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

Show 5102550100 per page
Top